Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Current Deferred Tax Assets: 2011-2015

Historic Current Deferred Tax Assets for Lifecore Biomedical (LFCR) over the last 5 years, with May 2015 value amounting to $2.1 million.

  • Lifecore Biomedical's Current Deferred Tax Assets rose 4.03% to $2.1 million in Q4 2015 from the same period last year, while for Nov 2015 it was $2.1 million, marking a year-over-year increase of 4.03%. This contributed to the annual value of $2.1 million for FY2015, which is 2.68% up from last year.
  • Latest data reveals that Lifecore Biomedical reported Current Deferred Tax Assets of $2.1 million as of FY2015, which was up 2.68% from $2.1 million recorded in FY2014.
  • Lifecore Biomedical's Current Deferred Tax Assets' 5-year high stood at $2.1 million during FY2015, with a 5-year trough of $542,000 in FY2011.
  • Its 3-year average for Current Deferred Tax Assets is $1.9 million, with a median of $2.1 million in 2014.
  • Its Current Deferred Tax Assets has fluctuated over the past 5 years, first soared by 283.03% in 2012, then declined by 23.80% in 2013.
  • Yearly analysis of 5 years shows Lifecore Biomedical's Current Deferred Tax Assets stood at $542,000 in 2011, then soared by 283.03% to $2.1 million in 2012, then decreased by 23.80% to $1.6 million in 2013, then grew by 29.96% to $2.1 million in 2014, then rose by 2.68% to $2.1 million in 2015.